Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pardoprunox (SLV-308) is a partial dopamine D2 agonist and noradrenergic agonist with serotonin 5-HT1A agonist properties. Pardoprunox has been used in trials studying the treatment of Early Stage Parkinson's Disease and Advanced Stage Parkinson's Disease.
説明 | Pardoprunox (SLV-308) is a partial dopamine D2 agonist and noradrenergic agonist with serotonin 5-HT1A agonist properties. Pardoprunox has been used in trials studying the treatment of Early Stage Parkinson's Disease and Advanced Stage Parkinson's Disease. |
ターゲット&IC50 | D3:8.6(pKi), D2:8.1(pKi) |
別名 | SLV-308, DU-126891 |
分子量 | 233.27 |
分子式 | C12H15N3O2 |
CAS No. | 269718-84-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mM
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Pardoprunox 269718-84-5 GPCR/G Protein Neuroscience Dopamine Receptor 5-HT Receptor Adrenergic Receptor inhibit Inhibitor Beta Receptor Serotonin Receptor SLV 308 DU 126891 SLV-308 DU-126891 DU126891 5-hydroxytryptamine Receptor SLV308 inhibitor